Hemolíticas. Keywords: Autoimmune hemolytic anemia, cold agglutinin disease, autoantibodies, treatment. Palabras clave: Anemia hemolitica autoinmune. Request PDF on ResearchGate | Protocolo diagnóstico de las anemias hemolíticas | The hemolytic anemias diagnosis remains a clinical challenge. Once a. Download Citation on ResearchGate | On Nov 1, , M. J. García Rodríguez and others published Protocolo diagnóstico de las anemias hemolíticas.

Author: Bacage Malakree
Country: Sao Tome and Principe
Language: English (Spanish)
Genre: Science
Published (Last): 8 May 2005
Pages: 454
PDF File Size: 17.75 Mb
ePub File Size: 18.46 Mb
ISBN: 296-1-56809-248-6
Downloads: 67732
Price: Free* [*Free Regsitration Required]
Uploader: Tasida

Roberto Ferreira Pinto Machado. Estima-se que em todo o mundo aproximadamente Dois outros estudos confirmam esses achados: Oximetria de pulso noturna. Patterns of mortality in sickle cell disease in the United Kingdom. Mortality in sickle cell disease.

Anemias hemolíticas (1)

Life expectancy and risk factors for early death. N Engl J Med.

Sickle cell chronic lung disease: Causes of death in sickle-cell disease in Jamaica. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: Systemic fat embolism and pulmonary hypertension in sickle cell disease.

Hematol Oncol Clin North Am. Pulmonary hypertension and cor pulmonale in the sickle hemoglobinopathies.

[Anemias hemoliticas].

Left ventricular filling pressure in sickle cell anemia. J Assoc Acad Minor Phys. Sickle cell heart disease. Two-dimensional echo and Doppler ultrasonographic findings in the hearts of adult patients with sickle cell anemia.

Pulmonary hypertension in sickle cell disease. Pulmonary hypertension and sickle hemoglobinopathy. Pulmonary hypertension in sickle cell hemoglobinopathy: Pulmonary hypertension in sickle cell disease: Pulmonary hypertension as a risk factor for death in patients anemiae sickle cell disease.


N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. Pulmonary hypertension in patients with sickle cell disease: Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.

The clinical sequelae of intravascular hemolysis and anmias plasma hemoglobin: Pulmonary hypertension after splenectomy? Pulmonary arterial hypertension in previously splenectomized patients with beta-thalassemic disorders. Recurrent thromboembolic disease following splenectomy for pyruvate kinase deficiency. Hereditary spherocytosis, thrombocytosis, and chronic pulmonary emboli: Intravenous injection of sonicated blood induces pulmonary anrmias in rabbits with ligation of the splenic artery.

Plasma “free” HB is related to red cell derived vesicle numbers in sickle cell anemia and thalassemia intermedia: Enhanced platelet reactivity and hypercoagulability in the steady state of sickle cell anaemia.

Blood proteins C and S in sickle cell disease. Changes in coagulation and fibrinolysis in patients with sickle cell disease compared with healthy black controls. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients. Decreased protein S activity in sickle cell disease. Nouv Rev Fr Hematol. Enhanced thrombin generation in children with sickle cell disease.

Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Causes of death in sickle cell disease: Pulmonary thromboembolism in beta-thalassemia intermedia: An extreme consequence of splenectomy in dehydrated hereditary stomatocytosis: Thrombo-embolic disease after splenectomy for hereditary stomatocytosis.


Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. J Am Coll Cardiol. Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary anemiaw. Sitaxsentan therapy for pulmonary arterial hypertension.

Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients hdmoliticas sickle cell disease. Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension. Efficacy and safety of sildenafil in the treatment anemiias severe pulmonary hypertension in patients with hemoglobinopathies.

Successful pulmonary thromboendarterectomy in two patients with sickle cell disease. Oxygen saturation with sleep in patients with sickle cell disease. Nocturnal oxygen saturation and painful sickle cell crises in children.

Mechanisms he,oliticas nocturnal oxyhemoglobin desaturation in hemolitlcas and adolescents with sickle cell disease. Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease.

Hypoxaemia in sickle cell disease: The effect of anticoagulant therapy in primary and anorectic drug-induced pulmonary hypertension. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. Long-term treatment with sildenafil in a thalassemic patient with pulmonary hypertension.

Hemodynamic studies in sickle cell anemia. Fax 1 E-mail: All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License.

Services on Demand Journal. SCS Quadra 1, Bl.

How to cite this article.